OBJECTIVE: Glucocorticoids remain a mainstay in the treatment of rheumatoid arthritis (RA). Dose-dependent adverse effects highlight the need for therapies that regulate glucocorticoid sensitivity to enable dosage reduction. Macrophage migration inhibitory factor (MIF) is a proinflammatory protein that has been implicated in the pathogenesis of RA; it impairs glucocorticoid sensitivity via MAPK phosphatase 1 (MKP-1) inhibition. The intracellular protein glucocorticoid-induced leucine zipper (GILZ) mimics the effects of glucocorticoids in models of RA, but whether it represents a target for the modulation of glucocorticoid sensitivity remains unknown. We undertook this study to investigate whether GILZ is involved in the regulation of glucocorticoid sensitivity by MIF. METHODS: GILZ expression was studied in the presence and absence of MIF, and the role of GILZ in the MIF-dependent regulation of the glucocorticoid sensitivity mediator MKP-1 was studied at the level of expression and function. RESULTS: GILZ expression was significantly inhibited by endogenous MIF, both basally and during responses to glucocorticoid treatment. The effects of MIF on GILZ were dependent on the expression and Akt-induced nuclear translocation of the transcription factor FoxO3A. GILZ was shown to regulate the expression of MKP-1 and consequent MAPK phosphorylation and cytokine release. CONCLUSION: MIF exerts its effects on MKP-1 expression and MAPK activity through inhibitory effects on GILZ. These findings suggest a previously unsuspected interaction between MIF and GILZ and identify GILZ as a potential target for the therapeutic regulation of glucocorticoid sensitivity.
OBJECTIVE: Glucocorticoids remain a mainstay in the treatment of rheumatoid arthritis (RA). Dose-dependent adverse effects highlight the need for therapies that regulate glucocorticoid sensitivity to enable dosage reduction. Macrophage migration inhibitory factor (MIF) is a proinflammatory protein that has been implicated in the pathogenesis of RA; it impairs glucocorticoid sensitivity via MAPK phosphatase 1 (MKP-1) inhibition. The intracellular protein glucocorticoid-induced leucine zipper (GILZ) mimics the effects of glucocorticoids in models of RA, but whether it represents a target for the modulation of glucocorticoid sensitivity remains unknown. We undertook this study to investigate whether GILZ is involved in the regulation of glucocorticoid sensitivity by MIF. METHODS:GILZ expression was studied in the presence and absence of MIF, and the role of GILZ in the MIF-dependent regulation of the glucocorticoid sensitivity mediator MKP-1 was studied at the level of expression and function. RESULTS:GILZ expression was significantly inhibited by endogenous MIF, both basally and during responses to glucocorticoid treatment. The effects of MIF on GILZ were dependent on the expression and Akt-induced nuclear translocation of the transcription factor FoxO3A. GILZ was shown to regulate the expression of MKP-1 and consequent MAPK phosphorylation and cytokine release. CONCLUSION:MIF exerts its effects on MKP-1 expression and MAPK activity through inhibitory effects on GILZ. These findings suggest a previously unsuspected interaction between MIF and GILZ and identify GILZ as a potential target for the therapeutic regulation of glucocorticoid sensitivity.
Authors: Timothy R D J Radstake; Fred C G J Sweep; Paco Welsing; Barbara Franke; Sita H H M Vermeulen; Anneke Geurts-Moespot; Thierry Calandra; Rachelle Donn; Piet L C M van Riel Journal: Arthritis Rheum Date: 2005-10
Authors: Konstantin V Salojin; Iris B Owusu; Karen A Millerchip; Mark Potter; Ken A Platt; Tamas Oravecz Journal: J Immunol Date: 2006-02-01 Impact factor: 5.422
Authors: Qiang Cheng; Huapeng Fan; Devi Ngo; Elaine Beaulieu; Patrick Leung; Camden Y Lo; Rosemary Burgess; Yvonne G van der Zwan; Stefan J White; Levon M Khachigian; Michael J Hickey; Eric F Morand Journal: J Immunol Date: 2013-05-31 Impact factor: 5.422
Authors: Qun Zhao; Xianxi Wang; Leif D Nelin; Yongxue Yao; Ranyia Matta; Mary E Manson; Reshma S Baliga; Xiaomei Meng; Charles V Smith; John A Bauer; Cheong-Hee Chang; Yusen Liu Journal: J Exp Med Date: 2005-12-27 Impact factor: 14.307
Authors: Michael Hammer; Jörg Mages; Harald Dietrich; Angela Servatius; Norma Howells; Andrew C B Cato; Roland Lang Journal: J Exp Med Date: 2005-12-27 Impact factor: 14.307
Authors: Mi-Jeong Lee; Rong-Ze Yang; Kalypso Karastergiou; Steven R Smith; Jeffery R Chang; Da-Wei Gong; Susan K Fried Journal: J Lipid Res Date: 2016-05-13 Impact factor: 5.922
Authors: Karolina A Zielińska; Lode de Cauwer; Sofie Knoops; Kristof Van der Molen; Alexander Sneyers; Jonathan Thommis; J Brian De Souza; Ghislain Opdenakker; Karolien De Bosscher; Philippe E Van den Steen Journal: Front Immunol Date: 2017-09-28 Impact factor: 7.561
Authors: Agata Lichawska-Cieslar; Roza Pietrzycka; Janusz Ligeza; Maria Kulecka; Agnieszka Paziewska; Agata Kalita; Dobrochna D Dolicka; Mateusz Wilamowski; Katarzyna Miekus; Jerzy Ostrowski; Michal Mikula; Jolanta Jura Journal: Oncotarget Date: 2018-01-16
Authors: Tali Lang; Jacinta P W Lee; Kirstin Elgass; Anita A Pinar; Michelle D Tate; Elizabeth H Aitken; Huapeng Fan; Sarah J Creed; Nadia S Deen; Daouda A K Traore; Ivo Mueller; Danielle Stanisic; Francesca S Baiwog; Colin Skene; Matthew C J Wilce; Ashley Mansell; Eric F Morand; James Harris Journal: Nat Commun Date: 2018-06-08 Impact factor: 14.919
Authors: Diane Apostolopoulos; Rangi Kandane-Rathnayake; Sudha Raghunath; Alberta Hoi; Mandana Nikpour; Eric F Morand Journal: Lupus Sci Med Date: 2016-11-22